p75 Neurotrophin Receptor Cleavage by α- and γ-Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: p75 neurotrophin receptor (p75NTR) is an important mediator of invasion of malignant gliomas, but its role in glioma proliferation is unknown.Results: p75NTR mediates proliferation of brain tumor-initiating cells (BTICs) via its cleavage and release of an intracellular domain. Conclusion: p75NTR also regulates proliferation of BTICs.Significance: p75NTR is a potential target for the treatment of malignant gliomas.Malignant gliomas are highly invasive, proliferative, and resistant to treatment.Previously, we have shown that p75 neurotrophin receptor (p75NTR) is a novel mediator of invasion of human glioma cells.However, the role of p75NTR in glioma proliferation is unknown.Here we used brain tumor-initiating cells (BTICs) and show that BTICs express neurotrophin receptors (p75NTR, TrkA, TrkB, and TrkC) and their ligands (NGF, brain-derived neurotrophic factor, and neurotrophin 3) and secrete NGF.Down-regulation of p75NTR significantly decreased proliferation of BTICs.Conversely, exogenouous NGF stimulated BTIC proliferation through ␣and ␥-secretasemediated p75NTR cleavage and release of its intracellular domain (ICD).In contrast, overexpression of the p75NTR ICD induced proliferation.Interestingly, inhibition of Trk signaling blocked NGF-stimulated BTIC proliferation and p75NTR cleavage, indicating a role of Trk in p75NTR signaling.Further, blocking p75NTR cleavage attenuated Akt activation in BTICs, suggesting role of Akt in p75NTR-mediated proliferation.We also found that p75NTR, ␣-secretases, and the four subunits of the ␥-secretase enzyme were elevated in glioblastoma multiformes patients.Importantly, the ICD of p75NTR was commonly found in malignant glioma patient specimens, suggesting that the receptor is activated and cleaved in patient tumors.These results suggest that p75NTR proteolysis is required for BTIC proliferation and is a novel potential clinical target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia-inducible factors and the response to hypoxic stress
Majmundar, A. J., Wong, W. J., & Simon, M. C. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.022 · Cited by 2,380 · cited 3×
“For example, p75NTR undergoes proteolytic cleavage and releases its ICD, which is required for 1) receptor-dependent inhibition of neurite outgrowth through Rho activation (49), 2) induction of apoptosis via TRAF6-dependent ubiquitination, nuclear translocation of NRIF, and activation of JNK (26, 27, 102), 3) cell sur…”
BackgroundA restricted cell population propagates glioblastoma growth after chemotherapy
Chen, J., Li, Y., Yu, T.-S., McKay, R. M., Burns, D. K., Kernie, S. G., & Parada, L. F. (2012) · Nature · doi:10.1038/nature11287 · Cited by 2,354
Neurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 2×
“Its effect ranges from neurite outgrowth to myelin formation to cell survival and death (20, 21).”
BackgroundNeurotrophin-regulated signalling pathways
Reichardt, L. F. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1894 · Cited by 2,195
Pollard, S. M., Yoshikawa, K., Clarke, I. D., Danovi, D., Stricker, S., Russell, R., Bayani, J., Head, R., Lee, M., Bernstein, M., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.014 · Cited by 1,025 · cited 9×
“They express neuronal stem cell markers, such as Nestin and Sox2, self-renew, potentially differentiate into many cell types that make up the tumor (10 –14, 62, 74, 75), and develop tumors when transplanted into immunodeficient mice, which resemble MGs found in human patients (8, 13, 14).”
BackgroundMethodInfluentialProliferation and differentiation of neuronal stem cells regulated by nerve growth factor
Cattaneo, E., & McKay, R. (1990) · Nature · doi:10.1038/347762a0 · Cited by 717 · cited 1×
“p75NTR is also implicated in regulating proliferation and differentiation of neuronal and non-neuronal cells (22, 23).”
BackgroundThe p75 receptor acts as a displacement factor that releases Rho from Rho-GDI
Yamashita, T., & Tohyama, M. (2003) · Nature Neuroscience · doi:10.1038/nn1045 · Cited by 460
Nykjaer, A., Willnow, T. E., & Petersen, C. M. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.01.004 · Cited by 318 · cited 1×
“Neurotrophin Receptors and Ligands Are Expressed in Brain Tumor-initiating Cells—Neurotrophins and their receptors (p75NTR, TrkA, TrkB, and TrkC) play important roles in regulating cell survival and proliferation in multiple cell types (20, 21, 28).”
Background
Cited by
Wang, X., Prager, B. C., Wu, Q., Kim, L. J. Y., Gimple, R. C., Shi, Y., Yang, K., Morton, A. R., Zhou, W., Zhu, Z., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.03.011 · Cited by 285
“Several studies have focused on the nerve growth factor receptor, p75NTR or CD271 (Ahn et al., 2016; Forsyth et al., 2014; Wang et al., 2008).”
Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice
Garofalo, S., D’Alessandro, G., Chece, G., Brau, F., Maggi, L., Rosa, A., Porzia, A., Mainiero, F., Esposito, V., Lauro, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7623 · Cited by 129
Neurotrophin receptors in the pathogenesis, diagnosis and therapy of neurodegenerative diseases
Meldolesi, J. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.024 · Cited by 53
Eggert, S., Kins, S., Endres, K., & Brigadski, T. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0330 · Cited by 46
Wang, Q., Wang, Y., Zhang, T., Jiao, S., Liu, Y., Zeng, F., Li, J., Yao, X., Zhou, H., Zhou, X., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13616 · Cited by 41
“…tumor necrosis factor-alpha-converting enzyme (TACE) to release its ectodomain (p75ECD) from cell surface, and its C-terminal fragment is further under the regulated-intramembranous proteolysis by gamma-secretase to generate the intracellular domain (Urra et al. 2007; Forsyth et al. 2014).”
Background
Metadata
- Authors
- Forsyth, P. A., Krishna, N., Lawn, S., Valadez, J. G., Qu, X., Fenstermacher, D. A., Fournier, M., Potthast, L., Chinnaiyan, P., Gibney, G. T., Zeinieh, M., Barker, P. A., Carter, B. D., Cooper, M. K., & Kenchappa, R. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 289
- Issue
- 12
- Pages
- 8067-8085
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2020211419
- Cited by
- 67
- References
- 8
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p75 Neurotrophin Receptor Cleavage by α- and γ-Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells. https://app.cochat.ai/papers/10.1074/jbc.m113.513762
- The paper
- Forsyth, P. A., Krishna, N., Lawn, S., Valadez, J. G., Qu, X., Fenstermacher, D. A., Fournier, M., Potthast, L., Chinnaiyan, P., Gibney, G. T., Zeinieh, M., Barker, P. A., Carter, B. D., Cooper, M. K., & Kenchappa, R. S. (2014). p75 Neurotrophin Receptor Cleavage by α- and γ-Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m113.513762
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.